Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3615534

FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    24.4.2018
  • EP published:
    15.9.2021
  • EP application number:
    18719178.8
  • Max expiry date:
    23.4.2038
  • Title:
    FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

Timeline

Today
24.4.2018EP application
15.9.2021EP Publication

Owner

  • Name:
    UCB Biopharma SRL
  • Address:
    Allée de la Recherche 60, 1070 Brussels, BE
  • Name:
    Sanofi
  • Address:
    54, rue La Boétie, 75008 Paris, FR

Inventor

  • Name:
    BROOKINGS, Daniel Christopher
  • Address:
    Slough Berkshire SL1 3WE, GB
  • Name:
    DE HARO GARCIA, Teresa
  • Address:
    Slough Berkshire SL1 3WE, GB
  • Name:
    FORICHER, Yann
  • Address:
    75008 Paris, FR
  • Name:
    HORSLEY, Helen Tracey
  • Address:
    Slough Berkshire SL1 3WE, GB
  • Name:
    HUTCHINGS, Martin Clive
  • Address:
    Slough Berkshire SL1 3WE, GB
  • Name:
    JOHNSON, James Andrew
  • Address:
    Slough Berkshire SL1 3WE, GB
  • Name:
    MACCOSS, Malcolm
  • Address:
    South Carolina 29455, US
  • Name:
    XUAN, Mengyang
  • Address:
    Slough Berkshire SL1 3WE, GB
  • Name:
    ZHU, Zhaoning
  • Address:
    Slough Berkshire SL1 3WE, GB

Priority

  • Number:
    17168027
  • Date:
    25.4.2017
  • Country:
    EP

Classification

  • Categories:
    A61K 31/4188, C07D 487/18, A61P 3/00, A61P 9/00, A61P 17/06, A61P 19/02, A61P 25/00, A61P 27/02, A61P 35/00, A61P 37/00, A61P 37/02, A61P 29/00

Upload documents